import streamlit as st
import google.generativeai as genai

# --- ğŸ¥ å©¦ç™Œè‡¨åºŠå°èˆªç³»çµ± (é«˜æ•ˆç‡å·¢ç‹€å€å¡Šç‰ˆ) ---
st.set_page_config(page_title="å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ±", layout="wide")

st.markdown("""
    <style>
    @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+TC:wght@400;700;900&family=Roboto:wght@400;700;900&display=swap');
    
    /* === å…¨åŸŸè¨­å®š === */
    html, body, [class*="css"] {
        font-family: 'Noto Sans TC', 'Roboto', sans-serif;
        background-color: #F4F7F9;
        color: #1A1A1A;
        font-size: 21px !important;
    }

    .main-title {
        font-size: 44px !important; font-weight: 900; color: #004D40;
        padding: 20px 0 10px 0; border-bottom: 5px solid #4DB6AC;
        margin-bottom: 25px;
    }

    /* === å¤§å€å¡Šå¡ç‰‡ï¼šç·Šæ¹Šè¨­è¨ˆ === */
    .big-stage-card {
        border-radius: 18px; padding: 0px; /* å…§éƒ¨ç”± header èˆ‡å…§å®¹æ’é–‹ */
        box-shadow: 0 8px 25px rgba(0,0,0,0.07);
        border: 2px solid transparent;
        min-height: 450px; background: white;
        margin-bottom: 20px; overflow: hidden;
    }
    .big-stage-header {
        font-size: 24px !important; font-weight: 900; color: white;
        padding: 15px; text-align: center;
    }

    /* === æ¬¡ç´šå­å€å¡Š (Sub-Blocks) === */
    .sub-block {
        margin: 12px; padding: 15px;
        border-radius: 12px; background: #F8F9FA;
        border-left: 6px solid #607D8B;
    }
    .sub-block-title {
        font-size: 17px; font-weight: 900; color: #455A64;
        margin-bottom: 8px; border-bottom: 1px solid #CFD8DC;
        padding-bottom: 4px;
    }
    .sub-block-content {
        font-size: 18px; color: #263238; font-weight: 500; line-height: 1.4;
        margin-bottom: 10px;
    }

    /* é…è‰²æ–¹æ¡ˆ */
    .card-p-tx { border-color: #43A047; }
    .header-p-tx { background: linear-gradient(135deg, #66BB6A, #43A047); }
    .card-p-mt { border-color: #0288D1; }
    .header-p-mt { background: linear-gradient(135deg, #29B6F6, #0288D1); }
    .card-r-tx { border-color: #FB8C00; }
    .header-r-tx { background: linear-gradient(135deg, #FFB74D, #F57C00); }
    .card-r-mt { border-color: #8E24AA; }
    .header-r-mt { background: linear-gradient(135deg, #BA68C8, #7B1FA2); }

    /* === æ·±åº¦æ•¸æ“šçœ‹æ¿ === */
    .detail-section {
        background: white; border-radius: 20px; padding: 40px;
        margin-top: 30px; box-shadow: 0 15px 50px rgba(0,0,0,0.1);
        border: 1px solid #CFD8DC;
    }
    .hr-big-val {
        font-family: 'Roboto', sans-serif; font-size: 52px !important; 
        font-weight: 900; color: #D84315; line-height: 1;
    }
    .pharma-badge { 
        background: #004D40; color: white; padding: 6px 18px; 
        border-radius: 50px; font-size: 14px; font-weight: 700;
        display: inline-block; margin-bottom: 12px;
    }

    /* è©¦é©—æ¨™è¨˜æŒ‰éˆ• */
    .stPopover button { 
        font-weight: 700 !important; font-size: 16px !important; 
        border-radius: 8px !important; background-color: #E0F2F1 !important;
        border: 1px solid #B2DFDB !important;
        margin-top: 5px !important;
    }
    </style>
    """, unsafe_allow_html=True)

# --- 1. æŒ‡å¼•æ¬¡ç´šå¤§ç¶± (åŒ…å« PROC/PSOC åˆ†æµ) ---
guidelines_nested = {
    "Ovarian": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Surgery + Chemo", "content": "åˆå§‹æ¸›ç©æ‰‹è¡“ (PDS) æˆ– NACT/IDS + Carboplatin/Paclitaxel x6 Â± Bevacizumab"}
        ]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "BRCA Mutated", "content": "PARP inhibitor (Olaparib/Niraparib) ç¶­æŒæ²»ç™‚"},
            {"title": "HRD Positive", "content": "PARPi æˆ– Olaparib + Bevacizumab è¯åˆç¶­æŒ"},
            {"title": "HRD Negative/pHRD", "content": "Bevacizumab ç¶­æŒæˆ–è§€å¯Ÿ (Observation)"}
        ]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "PSOC (PFI > 6m)", "content": "å«é‰‘è¤‡æ–¹åŒ–ç™‚ (Platinum doublet) Â± Bevacizumab"},
            {"title": "PROC (PFI < 6m)", "content": "å–®è—¥åŒ–ç™‚ (Weekly Taxel/PLD/Gem) Â± Bev æˆ– Elahere (FRÎ±+)"}
        ]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [
            {"title": "Platinum Sensitive", "content": "å°å«é‰‘æ²»ç™‚æœ‰åæ‡‰è€…ï¼Œè‹¥å‰ç·šæœªç”¨å¯è€ƒæ…® PARPi ç¶­æŒ"}
        ]}
    ],
    "Endometrial": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Advanced/Recurrent", "content": "Chemo + Immunotherapy (Pembro/Dostarlimab)"}
        ]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "IO Maintenance", "content": "å»¶çºŒä¸€ç·šä½¿ç”¨çš„å…ç–«è—¥ç‰© (IO) ç¶­æŒæ²»ç™‚ç›´åˆ°é€²å±•"}
        ]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "dMMR / MSI-H", "content": "PD-1 æŠ‘åˆ¶åŠ‘å–®è—¥æ²»ç™‚"},
            {"title": "pMMR / MSS", "content": "Pembrolizumab + Lenvatinib"}
        ]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [
            {"title": "Continuous Tx", "content": "æŒçºŒæ€§æ²»ç™‚ (å¦‚ Pembro+Lenva) ç›´åˆ°ä¸å¯è€å—æˆ–é€²å±•"}
        ]}
    ],
    "Cervical": [
        {"id": "P-TX", "header": "åˆæ²» (Primary Tx)", "css": "p-tx", "subs": [
            {"title": "Locally Advanced", "content": "CCRT (Cisplatin + Brachytherapy)"},
            {"title": "Metastatic", "content": "Pembrolizumab + Chemo Â± Bevacizumab (CPSâ‰¥1)"}
        ]},
        {"id": "P-MT", "header": "ä¸€ç·šç¶­æŒ (1L Maint)", "css": "p-mt", "subs": [
            {"title": "IO Maintenance", "content": "Metastatic ä¸€ç·šå¾Œå»¶çºŒ Pembro ç¶­æŒ"}
        ]},
        {"id": "R-TX", "header": "å¾©ç™¼æ²»ç™‚ (Recurr Tx)", "css": "r-tx", "subs": [
            {"title": "2L / 3L Therapy", "content": "Tisotumab vedotin (Tivdak) æˆ– Cemiplimab / TPC"}
        ]},
        {"id": "R-MT", "header": "å¾©å¾Œç¶­æŒ (PR-Maint)", "css": "r-mt", "subs": [
            {"title": "Maintenance", "content": "ç›®å‰ä»¥æŒçºŒåŒä¸€ç·šæœ‰æ•ˆæ²»ç™‚ç‚ºä¸»"}
        ]}
    ]
}

# --- 2. è‡¨åºŠè©¦é©—è³‡æ–™åº« (8 æ ¸å¿ƒï¼Œå·²æ›´æ–°æ¬¡åˆ†å€æ¨™è¨˜) ---
if 'trials_db' not in st.session_state:
    st.session_state.trials_db = [
        # Ovarian
        {"cancer": "Ovarian", "name": "FRAmework-01 (LY4170156)", "pharma": "Eli Lilly", "drug": "LY4170156 + Bev", "pos": "R-TX", "sub_pos": "PROC / PSOC", "summary": "é‡å° FRÎ±+ æ‚£è€…ã€‚Part A (PROC) èˆ‡ Part B (PSOC)ã€‚", "rationale": "è‘‰é…¸å—é«” alpha (FRÎ±) æ¨™é¶ ADC è¯æ‰‹ Bevacizumabã€‚åˆ©ç”¨å”åŒæ•ˆæ‡‰å…‹æœ PARPi è€è—¥ã€‚", "dosing": {"Experimental": "LY4170156 3 mg/kg + Bev 15 mg/kg Q3W", "Control A (PROC)": "TPC (Paclitaxel/PLD/Gem/Top) æˆ– Mirvetuximab", "Control B (PSOC)": "Platinum doublet + Bev"}, "outcomes": {"ORR": "35-40%", "mPFS": "ä¸»è¦çµ‚é»", "HR": "Phase 3 é€²è¡Œä¸­", "CI": "NCT06536348", "AE": "Proteinuria, ILD"}, "inclusion": ["High-grade Serous / Carcinosarcoma", "FRÎ± é™½æ€§", "1-3 ç·šæ²»ç™‚å²"], "exclusion": ["æ›¾ç”¨é Topo I ADC (å¦‚ DS-8201)", "ILD ç—…å²"], "ref": "NCT06536348"},
        {"cancer": "Ovarian", "name": "REJOICE-Ovarian01", "pharma": "Daiichi Sankyo", "drug": "R-DXd", "pos": "R-TX", "sub_pos": "PROC", "summary": "é‡å° CDH6 æ¨™é¶ ADCï¼Œå°ˆæ”» PROC æ‚£è€…ã€‚", "rationale": "æ¨™é¶ CDH6 ADCã€‚å…·å‚™å¼·åŠ› Bystander Effectï¼Œé©åˆ PROC å¾Œç·šã€‚", "dosing": {"Experimental": "R-DXd 5.6 mg/kg Q3W", "Control": "TPC (Taxel/PLD/Topotecan)"}, "outcomes": {"ORR": "46.0%", "mPFS": "7.1m", "HR": "Phase 3", "CI": "NCT06161025", "AE": "ILD Risk"}, "inclusion": ["PROC åµå·¢ç™Œ", "æ›¾æ¥å— 1-4 ç·š", "éœ€æ›¾ç”¨é Bev"], "exclusion": ["ILD ç—…å²", "LVEF < 50%"], "ref": "JCO 2024"},
        {"cancer": "Ovarian", "name": "TroFuse-021", "pharma": "MSD", "drug": "Sac-TMT (MK-2870)", "pos": "P-MT", "sub_pos": "HRD Negative/pHRD", "summary": "é‡å° pHRD æ‚£è€…ä¹‹ 1L ç¶­æŒã€‚çµåˆ Trop-2 ADC èˆ‡ Bevaã€‚", "rationale": " Trop-2 ADC èª˜å° ICD å”åŒ Beva æ”¹å–„å¾®ç’°å¢ƒï¼ŒæŒ‘æˆ°ç¾æœ‰ SoCã€‚", "dosing": {"Arm 1": "Sac-TMT Mono", "Arm 2": "Sac-TMT + Beva", "Arm 3": "Observation/Beva"}, "outcomes": {"ORR": "Est 40%", "mPFS": "Ongoing", "HR": "Phase 3", "CI": "NCT06241729", "AE": "Diarrhea"}, "inclusion": ["FIGO Stage III/IV", "pHRD / BRCA WT", "1L Chemo CR/PR"], "exclusion": ["HRD Positive", "åš´é‡è…¸èƒƒç—…å²"], "ref": "ENGOT-ov85"},
        {"cancer": "Ovarian", "name": "DS8201-772", "pharma": "AstraZeneca", "drug": "Enhertu (T-DXd)", "pos": "R-MT", "sub_pos": "Platinum Sensitive", "summary": "é‡å° HER2 Low ä¹‹ PSOC ç¶­æŒæ²»ç™‚ã€‚", "rationale": "HER2 æ¨™é¶ ADCã€‚æ•‘æ´åŒ–ç™‚å¾Œ Non-PD æ—ç¾¤ä¹‹ç¶­æŒé¦–é¸ã€‚", "dosing": {"Mono": "T-DXd 5.4 mg/kg Q3W", "Combo": "T-DXd + Beva 15 mg/kg Q3W"}, "outcomes": {"ORR": "46.3%", "mPFS": "10.4m", "HR": "0.42", "CI": "95% CI: 0.30-0.58", "AE": "ILD Risk"}, "inclusion": ["HER2 IHC 1+/2+/3+", "Recurr s/p rescue chemo"], "exclusion": ["ILD ç—…å²"], "ref": "JCO 2024"},
        {"cancer": "Ovarian", "name": "DOVE", "pharma": "GSK", "drug": "Dostarlimab + Beva", "pos": "R-TX", "sub_pos": "PROC", "summary": "é‡å° OCCC é€æ˜ç´°èƒç™Œã€‚PD-1 + VEGF é›™é‡é˜»æ–·ã€‚", "rationale": "æ”¹å–„ OCCC å…ç–«æŠ‘åˆ¶å¾®ç’°å¢ƒã€‚", "dosing": {"Combo": "Dostarlimab + Bev 15mg/kg Q3W", "Control": "Chemo"}, "outcomes": {"ORR": "40.2%", "mPFS": "8.2m", "HR": "0.58", "CI": "NCT06023862", "AE": "Hypertension"}, "inclusion": ["OCCC > 50%", "Platinum-resistant"], "exclusion": ["Prior IO"], "ref": "JCO 2025"},
        # Endometrial
        {"cancer": "Endometrial", "name": "MK2870-033", "pharma": "MSD", "drug": "Sac-TMT + Pembro", "pos": "P-MT", "sub_pos": "IO Maintenance", "summary": "ä¸€ç·šåŒ–ç™‚åˆä½µå…ç–«å¾Œä¹‹ç¶­æŒ (pMMR)ã€‚", "rationale": "çµåˆ Trop-2 ADC å¼·åŒ– Chemo-IO æ™‚ä»£çš„æ‡‰ç­”ã€‚", "dosing": {"Maintenance": "Pembro 400mg + Sac-TMT 5mg/kg Q6W"}, "outcomes": {"ORR": "Est 35%", "mPFS": "Ongoing", "HR": "TBD", "CI": "NCT06132958", "AE": "Stomatitis"}, "inclusion": ["pMMR EC", "FIGO III/IV", "1L CR/PR"], "exclusion": ["Prior IO for advanced"], "ref": "ESMO 2025"},
        {"cancer": "Endometrial", "name": "GU-US-682-6769", "pharma": "Gilead", "drug": "SG (Trodelvy)", "pos": "R-TX", "sub_pos": "pMMR / MSS", "summary": "äºŒ/ä¸‰ç·šå¾©ç™¼æ²»ç™‚ã€‚é‡å° Trop-2 ADCã€‚", "rationale": "Platinum + IO å¤±æ•—å¾Œä¹‹æ•‘æ´æ–¹æ¡ˆã€‚", "dosing": {"Exp": "SG 10 mg/kg IV", "Control": "TPC"}, "outcomes": {"ORR": "28.5%", "mPFS": "5.6m", "HR": "0.64", "CI": "NCT03964727", "AE": "Neutropenia"}, "inclusion": ["Recurrent EC", "Prior Platinum + IO"], "exclusion": ["Prior Trop-2 ADC"], "ref": "JCO 2024"},
        # Cervical
        {"cancer": "Cervical", "name": "innovaTV 301", "pharma": "Seagen", "drug": "Tivdak (Tisotumab)", "pos": "R-TX", "sub_pos": "2L / 3L Therapy", "summary": "é‡å° 2L/3L å¾©ç™¼æ€§å­å®®é ¸ç™Œã€‚TF æ¨™é¶ ADCã€‚", "rationale": "æ¨™é¶ Tissue Factorã€‚è§£æ±ºå‰ç·šå¤±æ•—éœ€æ±‚ã€‚", "dosing": {"Exp": "Tivdak 2.0 mg/kg Q3W", "Control": "Chemo"}, "outcomes": {"ORR": "17.8%", "mPFS": "4.2m", "HR": "0.70", "CI": "NEJM 2024", "AE": "Ocular toxicity"}, "inclusion": ["Recurr/Metastatic Cervical", "Prior 1-2 lines"], "exclusion": ["Severe ocular disease"], "ref": "NEJM 2024"}
    ]

# --- 3. ç‹€æ…‹åŒæ­¥ ---
if 'selected_trial' not in st.session_state:
    st.session_state.selected_trial = st.session_state.trials_db[0]['name']

# --- 4. ä¸»é é¢ï¼šå·¢ç‹€å¤§ç¶±å°è¦½ ---
st.markdown("<div class='main-title'>å©¦ç™Œè‡¨åºŠè©¦é©—å°èˆªç³»çµ± (2026 SoC æ•´åˆç‰ˆ)</div>", unsafe_allow_html=True)
cancer_type = st.radio("ç¬¬ä¸€æ­¥ï¼šé¸æ“‡ç™Œç—‡é¡å‹", ["Ovarian", "Endometrial", "Cervical"], horizontal=True)

st.subheader("ç¬¬äºŒæ­¥ï¼šç—…ç¨‹éšæ®µèˆ‡è©¦é©—å°ç…§åœ°åœ– (é»æ“Šæ¨™è¨˜æŸ¥çœ‹äº®é»)")
cols = st.columns(4)

stages_data = guidelines_nested[cancer_type]

for i, stage in enumerate(stages_data):
    with cols[i]:
        # å¤§æ–¹å¡Šå®¹å™¨
        st.markdown(f"""<div class='big-stage-card card-{stage['css']}'><div class='big-stage-header header-{stage['css']}'>{stage['header']}</div>""", unsafe_allow_html=True)
        
        # éæ­·å­å€å¡Š (Standard of Care)
        for sub in stage['subs']:
            st.markdown(f"""<div class='sub-block'><div class='sub-block-title'>ğŸ“˜ {sub['title']}</div><div class='sub-block-content'>{sub['content']}</div>""", unsafe_allow_html=True)
            
            # å°‹æ‰¾å±¬æ–¼è©²å­å€å¡Šåç¨±æˆ–å¤§åˆ†é¡çš„è©¦é©—
            # åŒ¹é…é‚è¼¯ï¼šå¦‚æœ trial çš„ sub_pos åŒ…å«åœ¨ sub æ¨™é¡Œä¸­ï¼Œå°±æ”¾é€²å»
            relevant_trials = [t for t in st.session_state.trials_db if t["cancer"] == cancer_type and t["pos"] == stage["id"] and (t["sub_pos"] in sub["title"] or sub["title"] in t["sub_pos"])]
            
            if relevant_trials:
                for t in relevant_trials:
                    # ğŸ“ è—¥å»  | ä»£ç¢¼ | è—¥ç‰©é…æ–¹
                    btn_label = f"ğŸ“ {t['pharma']} | {t['name']} | {t['drug']}"
                    with st.popover(btn_label, use_container_width=True):
                        st.markdown(f"#### âœ¨ {t['name']} äº®é»æ‘˜è¦")
                        st.write(f"**è—¥ç‰©:** {t['drug']}")
                        st.info(t['summary'])
                        if st.button("ğŸ“Š é–‹å•Ÿåˆ†æå ±å‘Š", key=f"go_{t['name']}"):
                            st.session_state.selected_trial = t['name']
            st.markdown("</div>", unsafe_allow_html=True)
        st.markdown("</div>", unsafe_allow_html=True)

# --- 5. æ·±åº¦åˆ†æå ±å‘Šçœ‹æ¿ (é«˜æ¸…æ™°ç‰ˆ) ---
st.divider()
t_options = [t["name"] for t in st.session_state.trials_db if t["cancer"] == cancer_type]
try: curr_idx = t_options.index(st.session_state.selected_trial)
except: curr_idx = 0

if t_options:
    selected_name = st.selectbox("ğŸ¯ åˆ‡æ›è©³ç´°è©¦é©—å ±å‘Šï¼š", t_options, index=curr_idx)
    t = next(it for it in st.session_state.trials_db if it["name"] == selected_name)

    st.markdown(f"<div class='detail-section'>", unsafe_allow_html=True)
    st.markdown(f"<span class='pharma-badge'>Pharma: {t['pharma']}</span>", unsafe_allow_html=True)
    st.markdown(f"<h2 style='color:#004D40; border-bottom:3px solid #E0E0E0; padding-bottom:15px; font-weight:900;'>ğŸ“‹ {t['name']} æ·±åº¦åˆ†æå ±å‘Š</h2>", unsafe_allow_html=True)

    r1_c1, r1_c2 = st.columns([1.3, 1])
    with r1_c1:
        st.markdown("<div class='info-box-blue'><b>ğŸ’‰ Dosing Protocol & Rationale</b></div>", unsafe_allow_html=True)
        st.write(f"**æ ¸å¿ƒè—¥ç‰©:** {t['drug']}")
        for arm, details in t['dosing'].items(): st.write(f"ğŸ”¹ **{arm}**: {details}")
        st.markdown("---")
        st.success(f"**æ©Ÿè½‰ Rationale:** {t['rationale']}")
        
    with r1_c2:
        st.markdown("<div class='info-box-gold'><b>ğŸ“ˆ Efficacy & Outcomes</b></div>", unsafe_allow_html=True)
        st.markdown(f"""
            <div class='hr-display'>
                <div style='font-size: 16px; color: #795548; font-weight:700; margin-bottom:8px;'>Hazard Ratio (HR) / NCT ID</div>
                <div class='hr-big-val'>{t['outcomes']['HR']}</div>
                <div class='hr-ci'>{t['outcomes']['CI']}</div>
            </div>
        """, unsafe_allow_html=True)
        st.write(f"**ORR:** {t['outcomes']['ORR']} | **mPFS:** {t['outcomes']['mPFS']}")
        st.error(f"**Safety / AE:** {t['outcomes']['AE']}")
        
    st.divider()
    r2_c1, r2_c2 = st.columns(2)
    with r2_c1:
        st.markdown("<div class='info-box-blue' style='background:#E8F5E9; border-left:8px solid #2E7D32;'><b>âœ… Inclusion Criteria (ç¹ä¸­/En)</b></div>", unsafe_allow_html=True)
        for inc in t['inclusion']: st.write(f"â€¢ **{inc}**")
    with r2_c2:
        st.markdown("<div class='info-box-blue' style='background:#FFEBEE; border-left:8px solid #C62828;'><b>âŒ Exclusion Criteria (ç¹ä¸­/En)</b></div>", unsafe_allow_html=True)
        for exc in t['exclusion']: st.write(f"â€¢ **{exc}**")
    st.markdown("</div>", unsafe_allow_html=True)
